Abstract:Objective To study the expression of cyclooxygenase-2 (COX-2) in the gastric epithelial carcinogensis and its relation with cell apoptosis and proliferation. Methods 15 cases of normal gastric mucosa (NGM), 30 cases of intestinal metaplasia (IM), 30 cases of dysplasia (Dys) and 40 cases of gastric cancer (GC) were used in this study. The expressions of COX-2 and proliferating cell nuclear antigen (PCNA) were detected by immunohistochemical SABC method, and cell apoptosis was measured by TUNEL. Results The expression level of COX-2 gradually increased from NGM, IM, Dys to GC. The positive rate of COX-2 in GC was 67.5%, 13.3% in NGM, and 33.3% in IM. There was a significant difference in COX-2 expression between GC and IM, GC and NGM(P0.05). Cell apoptosis index(AI) was 2.8±0.6 in GC. AI in GC was the lowest among all the pathological lesions (P0.01). Proliferation index (PI) from NGM, IM, Dys to GC also had an increasing tendency, and there were significant differences in PI between GC and the other precancerous lesions (P0.01). There was no significant difference in COX-2 expression among various precancerous lesions (P0.05). The expression of COX-2 in poorly differentiated cancer was markedly higher than that in well differentiated cancer (P0.05). The expression of both COX-2 and PI was closely correlated with the lymph node metastasis and vascular invasion of GC (P0.05). From NGM to IM, COX-2 expression level was positively correlated with AI (r=0.55,P0.05), but from Dys to GC, the negative correlation between COX-2 expression level and AI was observed (r=-0.56,P0.05). During gastric epithelial carcinogenesis, COX-2 expression was positively correlated with PI(r=0.61,P0.05). Conclusion COX-2 expression gradually increased during gastric epithelial carcinogenesis, and up-regulation of COX-2 may be an early event in this process. The expression level of COX-2 and PI may be helpful for evaluating the malignant degree metastasis and prognosis of GC. At the different stages of gastric carcinogenesis, COX-2 could stimulate cell proliferation, but at the early stages it promoted cell apoptosis, and inhibited cell apoptosis at the late stage.

Correlation of Expression of COX-2 to Clinical Pathological Characters and Its Catalytic Products in Gastric Carcinoma

Relationship Between Expression of COX-2 and Clinicopathological Characteristics in Human Gastric Cancer

Expression of cyclooxygenase 2 in colorectal cancer

Correlation of COX-2 Expression to Lymph Node Metastasis in Human Gastric Carcinoma

Expression of COX-2 in the Carcinogenesis of Gastric Epithelia and Its Correlation with Cell Apoptosis and Proliferation

Correlation Between Expression of Cyclooxygenase-2 and Invasiveness and Metastasis in Gastric Carcinoma

Correlation of COX-2 expression with microvascular and microlymphatic density in gastric carcinoma

Expression of Cyclooxygenase-2 in Gastric Cancer and Its Relation to Liver Metastasis and Long-Term Prognosis

The Study of Cyclooxygenase-2 Expression in Gastric Cancer

Expression of Cyclooxygenase in Gastric Carcinoma and Its Correlation with NF-kappaB

Expression of the cyclooxygenase-2 gene and its clinical significance in non-small cell lung cancer

The expreasion and its significance of COX-2 and MMP-2 in gastric carcinoma tissues

CORRELATION OF COX-2 AND VEGF EXPRESSIONS WITH CLINICAL PATHOLOGIC CHARACTERISTICS IN GASTRIC CARCINOMA

Expressions and Correlation of COX-2 and VEGF in Gastric Carcinoma

Expression of cyclooxyenase-2 and vascular endothelial cell growth factor in gastric carcinoma

[Expression of Tissue Microarray P53, P16 and Cyclooxygenase-2 in Gastric Cancer].

Expression of Cyclooxygenase-2 Protein in Human Gastric Cancer

Correlation of expressions of COX-2 and VEGF with angiogenesis in gastric carcinoma

Correlation between the expression of COX-2 and VEGF in gastric cancer and their clinical significance

Cyclooxygenase-2 expression correlates with angiogenesis and vascular endothelial growth factor-A in non-small cell lung cancer

Expression of COX-2 in Gastric Carcinoma and Its Relationship with VEGF